IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ascendis Pharma A/S (ASND)

CUSIP: 04351P101 | US | Healthcare · Biotechnology | Large Cap | 701 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Ferguson Wellman Capital Management, Inc2,600
0.0% of portfolio›$592.4K
StyleTurnoverLocationFiled
Ferguson Wellman Capital Management, Inc
2,600$592.4K0.0%CoreLowPortland, OR2026-10-05